메뉴 건너뛰기




Volumn 10, Issue 4, 2010, Pages 265-266

The ongoing debate about nodes

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN;

EID: 77955607297     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2010.n.033     Document Type: Editorial
Times cited : (2)

References (9)
  • 1
    • 77955651626 scopus 로고    scopus 로고
    • Axillary lymph node involvement in women with breast cancer: Does it depend on age?
    • Botteri E, Bagnardi V, Goldhirsch A, et al. Axillary lymph node involvement in women with breast cancer: does it depend on age? Clin Breast Cancer 2010; 10:318-321
    • (2010) Clin Breast Cancer , vol.10 , pp. 318-321
    • Botteri, E.1    Bagnardi, V.2    Goldhirsch, A.3
  • 2
    • 0035845511 scopus 로고    scopus 로고
    • Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    • Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci\USA 2001; 98:10869-10874
    • (2001) Proc Natl Acad Sci\USA , vol.98 , pp. 10869-10874
    • Sørlie, T.1    Perou, C.M.2    Tibshirani, R.3
  • 3
    • 34247145491 scopus 로고    scopus 로고
    • Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
    • [erratum published in: J Clin Oncol 2007; 25:3790]
    • Loi S, Haibe-Kains B, Desmedt C, et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade [erratum published in: J Clin Oncol 2007; 25:3790]. J Clin Oncol 2007; 25:1239-1246
    • (2007) J Clin Oncol , vol.25 , pp. 1239-1246
    • Loi, S.1    Haibe-Kains, B.2    Desmedt, C.3
  • 4
    • 19944422061 scopus 로고    scopus 로고
    • A multigene assay to predict recurrence of tamoxifen treated node negative breast cancer
    • Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen treated node negative breast cancer. N Engl J Med 2004; 351:2817-2826
    • (2004) N Engl J Med , vol.351 , pp. 2817-2826
    • Paik, S.1    Shak, S.2    Tang, G.3
  • 5
    • 0037137519 scopus 로고    scopus 로고
    • A gene-expression signature as a predictor of survival in breast cancer
    • van de Vijver MJ, He YD, van'tVeer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347:1999-2009.
    • (2002) N Engl J Med , vol.347 , pp. 1999-2009
    • Van De Vijver, M.J.1    He, Y.D.2    Van'T Veer, L.J.3
  • 6
    • 55249116037 scopus 로고    scopus 로고
    • Trial assessing individualized options for treatment for breast cancer: The TAILORx trial
    • Zujewski JA, Kamin L. Trial assessing individualized options for treatment for breast cancer: the TAILORx trial. Future Oncol 2008; 4:603-610
    • (2008) Future Oncol , vol.4 , pp. 603-610
    • Zujewski, J.A.1    Kamin, L.2
  • 7
    • 67650410053 scopus 로고    scopus 로고
    • MammaPrint 70-gene signature: Another milestone in personalized medical care for breast cancer patients
    • Slodkowska EA, Ross JS. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn 2009; 9:417-422
    • (2009) Expert Rev Mol Diagn , vol.9 , pp. 417-422
    • Slodkowska, E.A.1    Ross, J.S.2
  • 8
    • 77955616317 scopus 로고    scopus 로고
    • ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node
    • (abstract CRA506)
    • Giuliano AE, McCall LM, Beitsch PD, et al. ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. J Clin Oncol 2010; 28(15 suppl):69s (abstract CRA506).
    • (2010) J Clin Oncol , vol.28 , Issue.15 SUPPL.
    • Giuliano, A.E.1    McCall, L.M.2    Beitsch, P.D.3
  • 9
    • 77950512587 scopus 로고    scopus 로고
    • Breast cancer subtypes and the risk of local and regional relapse
    • Voduc D, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010; 28:1684-1691
    • (2010) J Clin Oncol , vol.28 , pp. 1684-1691
    • Voduc, D.1    Cheang, M.C.2    Tyldesley, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.